Mass SARS-CoV-2 Testing in a Dormitory-Style Correctional Facility in Arkansas

Lindsay K Tompkins1, Jayleen K L Gunn1, Blake Cherney1

  • 1Lindsay K. Tompkins and Allison E. James are with the Epidemic Intelligence Service, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Jayleen K. L. Gunn, Blake Cherney, Jason E. Ham, Roberta Horth, Rebecca Rossetti, William A. Bower, Kelsey Benson, Liesl M. Hagan, Matthew B. Crist, Shauna L. Mettee Zarecki, Meredith G. Dixon, Angela M. Starks, Zachary Weiner, Michael D. Bowen, Bettina Bankamp, Anna E. Newton, Naeemah Logan, Amy J. Schuh, Sean Trimble, Heidi Pfeiffer, Niu Tian, Francisco Ruiz, Kellen McDonald, Marlowe Thompson, Laura Cooley, Margaret A. Honein, and Dale A. Rose are with the COVID-19 Investigation Team, CDC. Charles Dusseau and Tara Ross are with the US Public Health Service Commissioned Corps, Rockville, MD. Jennifer A. Dillaha, Naveen Patil, H. Stewart Matthews, and Kelley Garner are with the Arkansas Department of Health, Little Rock. Jesica R. Jacobs is with the Laboratory Leadership Service, CDC.

Summary

Mass COVID-19 testing in correctional facilities revealed high SARS-CoV-2 prevalence, with most infected individuals being asymptomatic. Strict infection control and widespread testing are crucial to mitigate transmission in these settings.